Incidence of Diabetes After a COVID-19 Infection

CompletedOBSERVATIONAL
Enrollment

157,134

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

September 30, 2021

Study Completion Date

September 30, 2021

Conditions
COVID-19Diabetes Mellitus
Interventions
OTHER

no interventional study

no interventional study

Trial Locations (1)

Unknown

Center for Evidence-Based Healthcare, Technische Universität Dresden, Dresden

All Listed Sponsors
collaborator

Robert Koch Institut

OTHER_GOV

collaborator

Center for Evidence-Based Healthcare, Technische Universität Dresden

UNKNOWN

collaborator

Techniker Krankenkasse

OTHER

collaborator

BARMER

OTHER

collaborator

DAK Gesundheit

OTHER

collaborator

AOK PLUS

INDUSTRY

collaborator

Vandage GmbH

UNKNOWN

collaborator

IKK Classic

UNKNOWN

lead

InGef - Institute for Applied Health Research Berlin GmbH

INDUSTRY

NCT05524792 - Incidence of Diabetes After a COVID-19 Infection | Biotech Hunter | Biotech Hunter